Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. - Wikidata - awgldk - TriplyDB

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

http://www.wikidata.org/entity/Q36832437

about

Clinical utility of serum biomarkers in Duchenne muscular dystrophy The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscle Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation The mdx mouse model as a surrogate for Duchenne muscular dystrophy Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice.Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.Quantitative mass spectrometry of urinary biomarkers Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy Elusive sources of variability of dystrophin rescue by exon skipping Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy.Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Circulating Biomarkers for Duchenne Muscular Dystrophy.Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism.Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle Proteome dynamics during postnatal mouse corpus callosum development.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Proteomic profiling of the contractile apparatus from skeletal muscle.Chaperoning heat shock proteins: proteomic analysis and relevance for normal and dystrophin-deficient muscle.Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscle.Quantitative proteomics using SILAC: Principles, applications, and developments.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy.Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.NeuCode Proteomics Reveals Bap1 Regulation of Metabolism.Mass spectrometric identification of dystrophin, the protein product of the Duchenne muscular dystrophy gene, in distinct muscle surface membranes.Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin.Global in vivo terminal amino acid labeling for exploring differential expressed proteins induced by dialyzed serum cultivation.

P2860

Q26751261-BBB7209D-BBA8-4506-9803-A77297213259 Q26770343-342512BF-39BE-414D-B27C-14A0B5D90EBE Q27309883-1B2CE91B-BF89-4E58-886A-13478D34E2AD Q28656377-398060ED-6B56-483F-A1D1-42F2A8F1CDE6 Q33565229-01A22B88-6773-48C2-AFA3-9C3A4816A33D Q33675040-13594141-F279-4B11-8FA3-B9C1753F2EF4 Q33842215-B04FCCED-FF2D-4D80-B0E5-2E039F2F6240 Q33925571-3AA74342-E9C9-4892-B5A8-872ACF5C8F7D Q34555477-D86BA121-A636-4A29-A81C-95BF0F50F2A7 Q35051963-AE2079FD-0241-4ABA-A546-93CD7AD25B04 Q35201194-5A4C8BD4-C610-4D5A-B7C2-F81830E8F530 Q35599113-5BB787E9-5C13-46B8-B856-35826FEA0C7E Q35616824-8FFE16B5-0F85-4571-B166-13ED332D4E6C Q35837856-DCEA2FFA-8419-42DB-BD91-CF8317DBD2B3 Q36340978-3E28DFE9-19AC-45A0-A952-1E651F31E847 Q36371465-9136801A-4BE9-4925-8FFD-075A7F78CE9C Q36422465-10B1439D-B462-44B1-B394-6D7D4049D676 Q37196136-ECCA4813-F311-4901-9A89-85B091561C08 Q37372312-3CF73042-FA20-41EA-9427-ED573426A384 Q37566483-54E1507F-64D9-4A9A-A479-0B9F43CBDAA0 Q37610530-7A3B0311-CF17-4F12-8B41-BF57AD3D6B2E Q37633713-C55FFACA-668D-40E3-92A7-D9829E094FCC Q37688574-70E13B70-7792-4A18-BCC5-4D23FF8CFE4C Q37708368-0E19466A-0193-4684-912F-DCFE7A05BE8F Q37724316-3ABAF260-3DA0-4562-8857-10E2A69F4D09 Q38115148-06697589-7514-42B9-A929-84CBEB359C73 Q38115329-AF114061-4272-4576-B652-9EA191C337CC Q38217473-393E8B74-22F4-4859-91EE-10967636A667 Q38391853-E99730F7-BA2A-42B6-A0F5-FFAD638DEC4D Q38446973-94A97C02-3F18-48C9-9E49-14591753A2C6 Q38533946-C0BFED43-B434-4004-8608-6834D93EDC82 Q38563300-DDF5AE9B-4DC0-4EFF-A1B6-B18E667357FD Q38717697-F3750C72-2959-4CFB-BB95-478E781BF9CD Q38820669-1C788D81-D051-4A41-A855-DDC21425B478 Q38850056-D5BF4D9A-DD5C-46F2-AB21-0C7573631758 Q39033229-5F3A6A4E-7881-46AA-8165-DB1DA9C15780 Q41276922-92DC0EE7-161A-4027-914F-A7DDDAAA3721 Q41350434-F1DD6859-932E-4F59-BF14-66026F29558C Q44232941-14B0985E-86C5-4D44-A682-1EC9D814C4F3 Q45014723-5D784FF3-C569-4749-BACD-D7057FC8AF62

P2860

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

http://www.wikidata.org/entity/Q36832437

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Identification of disease spec ...... ystrophin deficient mdx mouse.

@en

type

label

Identification of disease spec ...... ystrophin deficient mdx mouse.

@en

prefLabel

Identification of disease spec ...... ystrophin deficient mdx mouse.

@en

P1433

Q36832437-3E3F9342-46CC-4366-A866-B8472201E020

P1476

Q36832437-CC701685-77BE-447C-B888-D1EB1734C180

P2093

Q36832437-169A214D-B7A8-45C1-8904-61ECFB915B91

Q36832437-34212DCA-9F94-40B0-AA0B-80FEEAA3EE21

Q36832437-4391B9A7-A085-45AC-A029-764A518EA7F5

Q36832437-56EB3674-B973-4EEC-B76F-B5681A9DBF72

Q36832437-7E2DB8E5-B4CA-4968-A244-9E96594CDACF

Q36832437-91D25C5E-6161-4F86-BD6D-6DF331B775A5

Q36832437-AF194B39-AA37-472F-952F-86081363D11E

Q36832437-BDF8CCD8-E648-4C5C-9883-24A755A78ACD

Q36832437-E9476724-E647-4B4D-8EA7-A92A95738B98

P2860

Q36832437-0797D7CC-AA49-40C9-9445-01CC24FED92B

Q36832437-08FD92C6-1A83-42B0-A46C-2E050459291E

Q36832437-097FF7E4-4892-42A9-AE28-2B5240B3A289

Q36832437-0B63BED5-73DC-4E71-87B3-3F432EF80638

Q36832437-11F14BC9-2FFC-4722-A06C-6664B5BE792F

Q36832437-13EBF767-56A0-4E02-8E35-61F326B62837

Q36832437-2F9EF322-1B59-49F0-8338-D979D22A3035

Q36832437-44AA2D79-E357-41A0-A14C-E56981746E02

Q36832437-46F995C7-CE5D-4F54-9F06-EF66FF8DB438

Q36832437-5F599ABE-3B24-473C-A8EF-768712EEDD34

P304

Q36832437-532B60A5-33EA-42D2-9A65-1382E9B5644F

P31

Q36832437-2BCEFE82-3341-4B93-ADA6-BA1B4E2A5A6A

P356

Q36832437-A9AB076E-FB0E-47CC-B2BD-3CA5B88EEC4A

P433

Q36832437-96F1435A-8579-4BC1-8A4F-C76362E5B377

P478

Q36832437-BBA0B2C0-FEA9-42FA-81AE-0F1FB45025FD

P50

Q36832437-442CB454-5313-4C0C-97F7-B11C9E3D7BD0

Q36832437-80D451B3-55ED-4D16-9358-0168A9010DE0

Q36832437-F6F4B423-3083-4149-A0F1-A4413CF47661

P577

Q36832437-BF52EC50-6584-45BC-AB3B-493D9F4D4284

P698

Q36832437-1E7BABD0-A54D-4DDB-B23D-45FF23A8AC2A

P932

Q36832437-BA47D9FB-1815-4FEC-89D9-F5059D4A6790

P356

MCP.M112.023127

P1433

Molecular & Cellular Proteomics

P1476

Identification of disease spec ...... dystrophin deficient mdx mouse

@en

P2093

Erdinc Cakir

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

Heather Grodish-Dressman

http://www.w3.org/2001/XMLSchema#string

Kristy J Brown

http://www.w3.org/2001/XMLSchema#string

Shin'ichi Takeda

http://www.w3.org/2001/XMLSchema#string

Vanessa Jahnke

http://www.w3.org/2001/XMLSchema#string

William Coley

http://www.w3.org/2001/XMLSchema#string

Yetrib Hathout

http://www.w3.org/2001/XMLSchema#string

Yoshitsugu Aoki

http://www.w3.org/2001/XMLSchema#string

P2860

A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC)

Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1

Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity.

Alteration in calcium handling at the subcellular level in mdx myotubes.

Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle.

Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP.

Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy.

Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.

P304

1061-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M112.023127

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Kanneboyina Nagaraju

Jyoti K. Jaiswal

Sree Rayavarapu

P577

2013-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23297347

http://www.w3.org/2001/XMLSchema#string

P932

3650321

http://www.w3.org/2001/XMLSchema#string